{"ORPHApacket":[{"ORPHApacketID":"165988","date":"2019-07-19 07:06:01","version":"1.2.11 \/ 4.1.6 [2018-04-12] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"165988","Name":[{"lang":"en","label":"Diazoxide-resistant diffuse hyperinsulinism"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_165988","DisorderType":[{"Name":[{"lang":"en","label":"Group of phenomes"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377794"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Diazoxide-resistant hyperinsulinism"}],"ORPHA":"276585","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_276585"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Disease definition"}],"Contents":"Diazoxide-resistant diffuse hyperinsulism (DRDH) is a form of Diazoxide resistant hyperinsulinism (see this term) characterized by recurrent episodes of profound hypoglycemia caused by an excessive\/ uncontrolled insulin secretion (inappropriate for the level of glycemia) due to diffuse involvement of pancreas that is unresponsive to medical treatment with diazoxide, often necessitating near total\/total pancreatectomy."}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"Hyperinsulinemic hypoglycemia, diazoxide-resistant diffuse form"}]}]}]}